tiprankstipranks
Innate Pharma (IPHA)
NASDAQ:IPHA
Want to see IPHA full AI Analyst Report?

Compare Innate Pharma (IPHA) vs. Competitors

132 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.66
$132.13M
-1.23
-34.99%
2 Buy
0 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$4.11
$885.34M
-18.84
204.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Therapeutics
$0.26
$55.93M
-0.95
-81.78%
1 Buy
1 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$13.55
$201.08M
-3.95
114.14%
4 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$16.59
$676.54M
0.02
4.77%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.44
-0.80
-35.69%
SLS
SELLAS Life Sciences Group
4.93
3.22
188.30%
SGMO
Sangamo Therapeutics
0.14
-0.59
-81.25%
GNFT
ELTX
Elicio Therapeutics
10.75
5.34
98.71%
VOR
Vor Biopharma
13.85
1.76
14.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts